These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
590 related articles for article (PubMed ID: 12351146)
1. Molecular genetics and function of NAT1 and NAT2: role in aromatic amine metabolism and carcinogenesis. Hein DW Mutat Res; 2002 Sep; 506-507():65-77. PubMed ID: 12351146 [TBL] [Abstract][Full Text] [Related]
2. Molecular genetics and epidemiology of the NAT1 and NAT2 acetylation polymorphisms. Hein DW; Doll MA; Fretland AJ; Leff MA; Webb SJ; Xiao GH; Devanaboyina US; Nangju NA; Feng Y Cancer Epidemiol Biomarkers Prev; 2000 Jan; 9(1):29-42. PubMed ID: 10667461 [TBL] [Abstract][Full Text] [Related]
3. Metabolic activation of N-hydroxy-2-aminofluorene and N-hydroxy-2-acetylaminofluorene by monomorphic N-acetyltransferase (NAT1) and polymorphic N-acetyltransferase (NAT2) in colon cytosols of Syrian hamsters congenic at the NAT2 locus. Hein DW; Doll MA; Gray K; Rustan TD; Ferguson RJ Cancer Res; 1993 Feb; 53(3):509-14. PubMed ID: 8425184 [TBL] [Abstract][Full Text] [Related]
4. Metabolic activation and deactivation of arylamine carcinogens by recombinant human NAT1 and polymorphic NAT2 acetyltransferases. Hein DW; Doll MA; Rustan TD; Gray K; Feng Y; Ferguson RJ; Grant DM Carcinogenesis; 1993 Aug; 14(8):1633-8. PubMed ID: 8353847 [TBL] [Abstract][Full Text] [Related]
5. Cloning, sequencing, and recombinant expression of NAT1, NAT2, and NAT3 derived from the C3H/HeJ (rapid) and A/HeJ (slow) acetylator inbred mouse: functional characterization of the activation and deactivation of aromatic amine carcinogens. Fretland AJ; Doll MA; Gray K; Feng Y; Hein DW Toxicol Appl Pharmacol; 1997 Feb; 142(2):360-6. PubMed ID: 9070359 [TBL] [Abstract][Full Text] [Related]
6. 4-Aminobiphenyl downregulation of NAT2 acetylator genotype-dependent N- and O-acetylation of aromatic and heterocyclic amine carcinogens in primary mammary epithelial cell cultures from rapid and slow acetylator rats. Jefferson FA; Xiao GH; Hein DW Toxicol Sci; 2009 Jan; 107(1):293-7. PubMed ID: 18842621 [TBL] [Abstract][Full Text] [Related]
7. Prostate expression of N-acetyltransferase 1 (NAT1) and 2 (NAT2) in rapid and slow acetylator congenic Syrian hamster. Hein DW; Doll MA; Xiao GH; Feng Y Pharmacogenetics; 2003 Mar; 13(3):159-67. PubMed ID: 12618593 [TBL] [Abstract][Full Text] [Related]
8. Rodent models of the human acetylation polymorphism: comparisons of recombinant acetyltransferases. Hein DW; Doll MA; Fretland AJ; Gray K; Deitz AC; Feng Y; Jiang W; Rustan TD; Satran SL; Wilkie TR Mutat Res; 1997 May; 376(1-2):101-6. PubMed ID: 9202744 [TBL] [Abstract][Full Text] [Related]
9. N-Acetyltransferase genetics and their role in predisposition to aromatic and heterocyclic amine-induced carcinogenesis. Hein DW Toxicol Lett; 2000 Mar; 112-113():349-56. PubMed ID: 10720751 [TBL] [Abstract][Full Text] [Related]
10. Effects of N-acetyl transferase 1 and 2 polymorphisms on bladder cancer risk in Caucasians. Gu J; Liang D; Wang Y; Lu C; Wu X Mutat Res; 2005 Mar; 581(1-2):97-104. PubMed ID: 15725609 [TBL] [Abstract][Full Text] [Related]
11. Acetylation of putative arylamine and alkylaniline carcinogens in immortalized human fibroblasts transfected with rapid and slow acetylator N-acetyltransferase 2 haplotypes. Leggett CS; Doll MA; States JC; Hein DW Arch Toxicol; 2021 Jan; 95(1):311-319. PubMed ID: 33136180 [TBL] [Abstract][Full Text] [Related]
12. Arylamine N-acetyltransferase 1 (NAT1) and 2 (NAT2) polymorphisms in susceptibility to bladder cancer: the influence of smoking. Okkels H; Sigsgaard T; Wolf H; Autrup H Cancer Epidemiol Biomarkers Prev; 1997 Apr; 6(4):225-31. PubMed ID: 9107426 [TBL] [Abstract][Full Text] [Related]
13. Construction of Syrian hamster lines congenic at the polymorphic acetyltransferase locus (NAT2): acetylator genotype-dependent N- and O-acetylation of arylamine carcinogens. Hein DW; Doll MA; Rustan TD; Gray K; Ferguson RJ; Feng Y Toxicol Appl Pharmacol; 1994 Jan; 124(1):16-24. PubMed ID: 8291057 [TBL] [Abstract][Full Text] [Related]
14. Human acetyltransferase polymorphisms. Grant DM; Hughes NC; Janezic SA; Goodfellow GH; Chen HJ; Gaedigk A; Yu VL; Grewal R Mutat Res; 1997 May; 376(1-2):61-70. PubMed ID: 9202739 [TBL] [Abstract][Full Text] [Related]
15. Role of aromatic amine acetyltransferases, NAT1 and NAT2, in carcinogen-DNA adduct formation in the human urinary bladder. Badawi AF; Hirvonen A; Bell DA; Lang NP; Kadlubar FF Cancer Res; 1995 Nov; 55(22):5230-7. PubMed ID: 7585581 [TBL] [Abstract][Full Text] [Related]
16. Association of prostate cancer with rapid N-acetyltransferase 1 (NAT1*10) in combination with slow N-acetyltransferase 2 acetylator genotypes in a pilot case-control study. Hein DW; Leff MA; Ishibe N; Sinha R; Frazier HA; Doll MA; Xiao GH; Weinrich MC; Caporaso NE Environ Mol Mutagen; 2002; 40(3):161-7. PubMed ID: 12355549 [TBL] [Abstract][Full Text] [Related]
17. N-acetyltransferase 2 acetylator genotype-dependent N-acetylation of 4-aminobiphenyl in cryopreserved human hepatocytes. Habil MR; Doll MA; Hein DW Pharmacogenet Genomics; 2020 Apr; 30(3):61-65. PubMed ID: 31895247 [TBL] [Abstract][Full Text] [Related]
18. Monomorphic and polymorphic human arylamine N-acetyltransferases: a comparison of liver isozymes and expressed products of two cloned genes. Grant DM; Blum M; Beer M; Meyer UA Mol Pharmacol; 1991 Feb; 39(2):184-91. PubMed ID: 1996083 [TBL] [Abstract][Full Text] [Related]
19. N-acetyltransferase NAT1 and NAT2 genotypes and lung cancer risk. Bouchardy C; Mitrunen K; Wikman H; Husgafvel-Pursiainen K; Dayer P; Benhamou S; Hirvonen A Pharmacogenetics; 1998 Aug; 8(4):291-8. PubMed ID: 9731715 [TBL] [Abstract][Full Text] [Related]
20. Role of N-acetyltransferase 2 acetylation polymorphism in 4, 4'-methylene bis (2-chloroaniline) biotransformation. Hein DW; Zhang X; Doll MA Toxicol Lett; 2018 Feb; 283():100-105. PubMed ID: 29180287 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]